L-Clausenamide
Code | Size | Price |
---|
TAR-T32614-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T32614-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T32614-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
L-clausenamide has the potential to be a multi-target treatment for Alzheimer's disease.
CAS:
201529-58-0
Formula:
C18H19NO3
Molecular Weight:
297.354
Purity:
0.98
SMILES:
CN1[C@@H]([C@@H](O)c2ccccc2)[C@H]([C@H](O)C1=O)c1ccccc1
References
1. Liu SL, Zhang JT. Effects of naloxone on l-clausenamide-induced long-term potentiation in dentate gyrus of anesthetized rats. Zhongguo Yao Li Xue Bao. 1999 Feb;20(2):112-6. PubMed PMID: 10437155.
2. Zhao MR, Zhang JT. Effects of 7-nitroindazole on long-term potentiation induced by l-clausenamide and high-frequency stimulation in rat hippocampus in vivo. Zhongguo Yao Li Xue Bao. 1999 Apr;20(4):319-23. PubMed PMID: 10452116.